MedPath

The role of novel biomarker HE4 in the follow-up of ovarian cancer

Not Applicable
Conditions
ovarian cancer, follopian tube cancer, primary peritoneal cancer
Registration Number
JPRN-UMIN000038016
Lead Sponsor
Jichi Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

1. other malignancy 2. Patients judged inappropriate by the doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath